JHBPS:活体肝移植患者红细胞分布宽度与输血的关系:倾向评分分析

2022-04-27 网络 网络

本研究调查了 LDLT 受者的红细胞分布宽度 (RDW) 与术中输血之间的关系。研究证实术前 RDW 是 LDLT 受者术中输血的潜在预测指标

肝移植(LT)是终末期肝病患者最复杂的手术之一,是外科医生和麻醉师面临的巨大挑战。尽管人们努力寻找肝移植术中出血和输血的预测因子,但目前仅获得的信息有限。红细胞分布宽度(RDW)是测量血液样本中红细胞大小的变化和标准全血细胞计数的一部分,最近的几项研究报道,RDW与某些疾病和程序的出血风险和输血相关。

然而,关于预测活体肝移植(LDLT)输血的指标的信息是有限的。本研究调查了 LDLT 受者的红细胞分布宽度 (RDW) 与术中输血之间的关系。

本研究分析了 2010 年 1 月-2019 年 10 月期间接受 LDLT 的 2546 名患者。根据术前 RDW 截止水平(<14.4 和≥14.4)将患者分为两组。研究人员进行了多变量回归分析来评估RDW与术中输血之间的关联,还进行了倾向评分匹配分析,以比较两组术中输血的发生率。RDW 的预测能力通过接受者操作特征 (ROC)、综合辨别改进 (IDI) 和净重分类改进 (NRI) 分析进行评估。

图1:活体供肝移植患者术中输血时红细胞分布宽度的roc曲线

 

表1:术中输血调整RDW截断水平(≥14.4)

表2:评价RDW对预测术中输血的附加价值.*模型1=年龄+性别+BMI+DM+HTN+剖腹手术史+CAD+门静脉血栓形成+腹水+MELD评分+病因学+HCC+血红蛋白<12+INR>1.3+血小板<70k+纤维蛋白原<160。†模型2=模型1+RDW≥14.4

在多变量逻辑分析中,RDW  14.4 与术中输血显着相关(优势比 [OR]:1.53,95% 置信区间 [CI]:1.13-2.06,P = 0.005)。两组术中输血发生率在匹配前(54.1% vs. 91.6%,P <0.001)和匹配后(71.6% vs. 79.8%,P =0.004)差异有统计学意义。RDW 对术中输血具有预测能力(NRI中P <0.001,IDI 中P =0.035)。

总的来说,研究人员发现术前RDW≥14.4与LDLT患者术中输血密切相关。这些结果表明,术前RDW可以作为LDLT受者术中输血的有用预测指标。

 

原始出处:

Sim, J.-H., Kwon, H.-M., Jun, I.-G., Kim, S.-H., Kim, B., Kim, S., Song, J.-G. and Hwang, G.-S. (2022), Association between red blood cell distribution width and blood transfusion in patients undergoing living donor liver transplantation: propensity score analysis. J Hepatobiliary Pancreat Sci. Accepted Author Manuscript. https://doi.org/10.1002/jhbp.1163.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1670205, encodeId=a7fa16e02059b, content=<a href='/topic/show?id=0329e715658' target=_blank style='color:#2F92EE;'>#红细胞分布宽度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77156, encryptionId=0329e715658, topicName=红细胞分布宽度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=642526597709, createdName=一闲, createdTime=Thu Sep 22 00:24:09 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005552, encodeId=a99920055524b, content=<a href='/topic/show?id=a00c364e3b' target=_blank style='color:#2F92EE;'>#BPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3647, encryptionId=a00c364e3b, topicName=BPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sat Mar 11 14:24:09 CST 2023, time=2023-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259747, encodeId=97561259e47e1, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Apr 28 13:24:09 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282104, encodeId=8412128210490, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Apr 28 13:24:09 CST 2022, time=2022-04-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1670205, encodeId=a7fa16e02059b, content=<a href='/topic/show?id=0329e715658' target=_blank style='color:#2F92EE;'>#红细胞分布宽度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77156, encryptionId=0329e715658, topicName=红细胞分布宽度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=642526597709, createdName=一闲, createdTime=Thu Sep 22 00:24:09 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005552, encodeId=a99920055524b, content=<a href='/topic/show?id=a00c364e3b' target=_blank style='color:#2F92EE;'>#BPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3647, encryptionId=a00c364e3b, topicName=BPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sat Mar 11 14:24:09 CST 2023, time=2023-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259747, encodeId=97561259e47e1, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Apr 28 13:24:09 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282104, encodeId=8412128210490, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Apr 28 13:24:09 CST 2022, time=2022-04-28, status=1, ipAttribution=)]
    2023-03-11 tsing_hit
  3. [GetPortalCommentsPageByObjectIdResponse(id=1670205, encodeId=a7fa16e02059b, content=<a href='/topic/show?id=0329e715658' target=_blank style='color:#2F92EE;'>#红细胞分布宽度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77156, encryptionId=0329e715658, topicName=红细胞分布宽度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=642526597709, createdName=一闲, createdTime=Thu Sep 22 00:24:09 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005552, encodeId=a99920055524b, content=<a href='/topic/show?id=a00c364e3b' target=_blank style='color:#2F92EE;'>#BPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3647, encryptionId=a00c364e3b, topicName=BPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sat Mar 11 14:24:09 CST 2023, time=2023-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259747, encodeId=97561259e47e1, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Apr 28 13:24:09 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282104, encodeId=8412128210490, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Apr 28 13:24:09 CST 2022, time=2022-04-28, status=1, ipAttribution=)]
    2022-04-28 windight
  4. [GetPortalCommentsPageByObjectIdResponse(id=1670205, encodeId=a7fa16e02059b, content=<a href='/topic/show?id=0329e715658' target=_blank style='color:#2F92EE;'>#红细胞分布宽度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77156, encryptionId=0329e715658, topicName=红细胞分布宽度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=642526597709, createdName=一闲, createdTime=Thu Sep 22 00:24:09 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005552, encodeId=a99920055524b, content=<a href='/topic/show?id=a00c364e3b' target=_blank style='color:#2F92EE;'>#BPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3647, encryptionId=a00c364e3b, topicName=BPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sat Mar 11 14:24:09 CST 2023, time=2023-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259747, encodeId=97561259e47e1, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Apr 28 13:24:09 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282104, encodeId=8412128210490, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Apr 28 13:24:09 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

拓展阅读

重度ACLF患者肝移植(LT)后1年死亡率(SALT-M)

重度ACLF患者肝移植(LT)后1年死亡率(SALT-M)

【热点解读】成人肝移植病人围术期体温管理最佳证据总结

本研究总结提炼的肝移植病人围术期体温管理的最佳证据,可为临床护理提供循证证据,有效指导临床护士进行围术期体温管理,以降低低体温发生率。

Nature封面:西京团队窦科峰、杨开山主导全球首例基因编辑猪肝移植进入人体

动物研究中优化的免疫抑制方案,并不一定适合人类受体。但以脑死亡患者为移植受体,则可使用临床免疫抑制药物,继而得出最优化的临床异种器官移植免疫抑制策略。

Cell Stem Cell:惠利健团队利用微囊化可增殖人肝细胞类器官实现肝衰竭治疗

该研究大量生产了得到质量控制的ProliHHs,并被改造成肝类器官,以提高它们的成熟度。

J Hepatol:肝移植后多重耐药菌感染

肝移植术后MDR感染发生率高,对预后有重要影响。屎肠球菌是最常见的多重耐药微生物。对于有高危因素的患者,应考虑新的药物和监测策略,以预防肝移植术后MDR感染。

肝移植手术术中心搏骤停一例

术中心搏骤停,是手术室内最严重的事件之一。成功的救治,来源于血淋漓的经验教训。

2024 APASL临床实践指南:肝移植

亚太肝脏研究学会(APASL,Asian-Pacific Association for the Study of the Liver) · 2024-02-28

2023 ESOT共识声明:原发性硬化性胆管炎(PSC)伴或不伴炎性肠病(IBD)的肝移植治疗

欧洲器官移植学会(ESOT,European Society for Organ Transplantation) · 2023-09-29